Insulin-like growth factor 1 treatment extends longevity in a mouse model of human premature aging by restoring somatotroph axis function
2010

Restoring Growth Hormone Balance to Treat Premature Aging

publication Evidence: moderate

Author Information

Author(s): Ugalde Alejandro P., Mariño Guillermo, López-Otín Carlos

Primary Institution: Universidad de Oviedo

Hypothesis

Can restoring the balance of growth hormone and insulin-like growth factor-1 (IGF-1) extend lifespan in progeroid mice?

Conclusion

Restoring the GH/IGF-1 balance in progeroid mice significantly extends their lifespan and delays aging features.

Supporting Evidence

  • Zmpste24−/− mice show high levels of growth hormone and low levels of IGF-1.
  • Treatment with recombinant IGF-1 restored the GH/IGF-1 balance in progeroid mice.
  • Restoration of IGF-1 levels significantly extended the lifespan of treated mice.

Takeaway

Scientists found that giving a special treatment to sick mice helped them live longer and feel better, just like how some people can live longer by eating less.

Methodology

The study involved treating Zmpste24−/− mice with recombinant IGF-1 to assess its effects on lifespan and aging features.

Limitations

The study primarily focused on a specific mouse model, which may not fully represent human conditions.

Participant Demographics

The study used Zmpste24−/− mice, which exhibit features of human progeroid syndromes.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication